By continuing to access the site you are agreeing to their use. Learn more about cookies. hamburger-icon INVESTORS CEO Q&A Clinigen CEO, Shaun Chilton, discusses the Group’s performance in 2021 and addresses some common questions received from investors over the past year. Tell us about the Group's financial results this year COVID-19 has forced massive change on the way the pharmaceutical industry does business. How has Clinigen responded? Is the structure of the business now right to drive future growth? What are the most important drivers of growth across the business? There have been a number of acquisitions in recent years. How have they contributed to the Group? Help us understand the synergies between the Products and Services business? How would you view this year's progress against your strategic objectives? Where are the Group's greatest opportunities? What do you think ESG looks like for the industry and how are you addressing this at Clinigen? What are the major milestones to look out for in 2022? What does success look like? What is your five-year vision for Clinigen? RELATED LINKS ANNUAL REPORT ANNUAL REPORT 2021 Download report (pdf 4.64mb) INVESTORS FINANCIAL HIGHLIGHTS View INVESTORS INVESTMENT CASE Read more OUR GLOBAL OFFICES United Kingdom Europe Asia, Pacific and Japan South Africa United States SITE TOOLS Stay In Touch AE Reporting Medical enquiries Terms of use Cookies Privacy policy Privacy Statement for Pharmacovigilance Data UK Gender Pay Gap Report Modern Slavery Statement Access Online Sitemap Consumer Information Obligations Clinigen Terms And Conditions Of Business (Sales) Clinigen Terms And Conditions Of Business (Purchases) FIND A MEDICINE Online services for healthcare professionals Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Twitter Linkedin © Copyright 2021 Clinigen Group plc. By Emperor

By continuing to access the site you are agreeing to their use. Learn more about cookies. hamburger-icon RESULTS, REPORTS AND PRESENTATIONS 2021 2020 2019 2018 Archive 30 SEP 2021 ANNUAL REPORT 2021 RELATED MATERIALS PDF (4.64MB) 16 SEP 2021 FULL YEAR RESULTS FOR THE YEAR ENDED 30 JUNE 2021 RELATED MATERIALS PDF (664.26KB) Presentation (pdf 1.73MB) Listen to the webcast 13 JUL 2021 YEAR END TRADING UPDATE RELATED MATERIALS PDF (241.30KB) Presentation (pdf 667.51KB) Webcast 23 FEB 2021 HALF YEAR RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2020 RELATED MATERIALS PDF (626.47KB) Presentation (pdf 1.73MB) Webcast 14 JAN 2021 HALF YEAR TRADING UPDATE RELATED MATERIALS PDF (271.05KB) OUR GLOBAL OFFICES United Kingdom Europe Asia, Pacific and Japan South Africa United States SITE TOOLS Stay In Touch FIND A MEDICINE Online services for healthcare professionals Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Twitter Linkedin © Copyright 2021 Clinigen Group plc. By Emperor